PolyPid

PolyPid OCF/Debt

The Operating Cash Flow to Debt Ratio of PolyPid (PYPD) as of Oct 11, 2026 is -997.10 %. In the previous year, Operating Cash Flow to Debt Ratio was -228.38 % — a change of 336.60% (lower).

OCF/Debt

-997.10 %

YoY

336.60%

Last updated:

Operating Cash Flow to Debt Ratio of PolyPid is 2025 -997.10 % . Operating Cash Flow to Debt Ratio of PolyPid was 2024 -228.38 % . It decreases by 336.60% lower compared to the previous year.

The PolyPid OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2015
-3,405.70 USD
Jan 1, 2016
-147.11 USD
Jan 1, 2017
-25.98 USD
Jan 1, 2022
-249.94 USD
Jan 1, 2023
-146.33 USD
Jan 1, 2024
-228.38 USD
Jan 1, 2025
-997.10 USD
The PolyPid OCF/Debt history
YEAROCF/DebtYoY
-997.10 %+336.60%
-228.38 %+56.07%
-146.33 %-41.46%
-249.94 %+862.23%
-25.98 %-82.34%
-147.11 %-95.68%
-3,405.70 %—
Access this data via the Eulerpool API

PolyPid Stock analysis

What does PolyPid do? PolyPid Ltd is an innovative, emerging company in the field of biomedical technology based in Israel. The company was founded in 2008 and has since gained continuous recognition and growth. PolyPid's core business is the development and manufacturing of implantable polymer systems that contribute to wound healing. These polymer systems are specifically introduced into the affected area of the body and continuously release active substances to prevent infections and promote natural healing processes. PolyPid's business model is focused on effectively solving patients' problems. The company has developed a wide range of products and technologies that specifically target various medical applications. These include orthopedics, traumatology, urology, and gynecology. For orthopedics, PolyPid provides various products and technologies that can be used in knee and hip joint surgeries. These include antibiotic-releasing implants to prevent infections and resorbable bone fillers that allow for faster and more effective wound healing. In the field of traumatology, PolyPid manufactures polymer systems that are used in the treatment of bone fractures or other traumas. Here again, the polymer systems ensure continuous release of active substances to prevent infections and promote natural healing processes. PolyPid also offers innovative solutions for urology. Specifically, products are developed to combat urinary tract infections and promote faster wound healing after urological surgeries. For gynecology, PolyPid offers polymer systems that can be used particularly in the postoperative phase to prevent infections and achieve faster wound healing. PolyPid has earned an excellent reputation in the industry in recent years due to its consistent focus on innovation and quality. To continually improve their products, the company invests heavily in research and development and maintains close contact with medical institutions and professionals worldwide. PolyPid is an important partner in the field of biomedical technology and has already received numerous awards for its groundbreaking products and developments. Thanks to its focus on quality, reliability, and innovation, the company will continue to play a key role in the biomedical technology market. PolyPid is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PolyPid stock

Operating Cash Flow to Debt Ratio of PolyPid is -997.10 % in 2025.

Operating Cash Flow to Debt Ratio of PolyPid changed from -228.38 % to -997.10 %, representing a 336.60% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio PolyPid since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's PolyPid with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — PolyPid

All Key Metrics — PolyPid